Evaluation of the effectiveness of zinc supplementation in children with urinary tract infection

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138903094056N1

Enrollment

200

Registered

2010-06-13

Start date

2008-04-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract infection. Urinary tract infection, site not specified

Interventions

In the control group without zinc supplementation

Intervention 1: In the case group with zinc sulfate (1mg/kg/day). Intervention 2: In the control group without zinc supplementation.

Treatment - Drugs

In the case group with zinc sulfate (1mg/kg/day)

Eligibility

Sex/Gender

Female

Age

3 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Female children 3 to 12 years old with UTI, without norogenic bladder, anatomical abnormalities, or any other malformations or kidney stones Exclusion criteria: Lack of patient cooperation, inappropriate use of prescribed drugs, history of recurrent UTI, those who have been treated for their UTI with drugs other than Ceftriaxon and Cefoxim

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Urinary Tract Infection. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Results of urine tests.;Dysuria. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Results of urine tests.;Abdominal pain. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child.;Fever. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Thermometer.;Frequency. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Results of urine tests.	—

Measure

Time frame

Urinary Tract Infection. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Results of urine tests.;Dysuria. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Results of urine tests.;Abdominal pain. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child.;Fever. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Thermometer.;Frequency. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Results of urine tests.

—

Secondary

Measure	Time frame
Anorexia. Timepoint: 14 days after treatment. Method of measurement: Mother and child statement.;Growth failure. Timepoint: 6 months after treatment. Method of measurement: Mother's remarks.;Weight loss. Timepoint: Three month after treatment. Method of measurement: Mother's remarks.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Parsa Yousefi

Arak University of Medical Sciences

parsayousefichaijan@yahoo.com+98 86 1417 3517

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026